Michael Rogers
2013 - Acorda Therapeutics
In 2013, Michael Rogers earned a total compensation of $4.4M as Chief Financial Officer at Acorda Therapeutics.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $47,200 |
| Option Awards | $2,450,174 |
| Salary | $93,939 |
| Stock Awards | $1,637,496 |
| Other | $23,965 |
| Total | $4,352,774 |
Rogers received $2.5M in option awards, accounting for 56% of the total pay in 2013.
Rogers also received $100K in bonus, $47.2K in non-equity incentive plan, $93.9K in salary, $1.6M in stock awards and $24K in other compensation.
Rankings
In 2013, Michael Rogers' compensation ranked 1,539th out of 12,286 executives tracked by ExecPay. In other words, Rogers earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,539 out of 12,286 | 88th |
Division Manufacturing | 506 out of 4,612 | 89th |
Major group Chemicals And Allied Products | 135 out of 1,462 | 91st |
Industry group Drugs | 92 out of 1,156 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 11 out of 196 | 94th |
Source: SEC filing on April 29, 2016.
Rogers' colleagues
We found six more compensation records of executives who worked with Michael Rogers at Acorda Therapeutics in 2013.
2013
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2013
Jane Wasman
Acorda Therapeutics
General Counsel
2013
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2013
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2013
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2013
David Lawrence
Acorda Therapeutics